AspirinPyrazolesAnti-Inflammatory Agents, Non-SteroidalSulfonamidesCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesIbuprofenDiclofenacNaproxenCyclooxygenase 1Platelet Aggregation InhibitorsSulfonesGastrointestinal DiseasesLactonesDinoprostoneAcetaminophenIndomethacinThiazinesIsoenzymesThromboxane B2EtodolacGastrointestinal HemorrhageSulindacDrug Therapy, CombinationDose-Response Relationship, DrugStomach UlcerOsteoarthritisKetoprofenSalicylatesAnticarcinogenic AgentsAnalgesics, Non-NarcoticTiclopidineNitrobenzenesPiroxicamPlatelet AggregationGastric MucosaProstaglandinsDouble-Blind MethodMembrane ProteinsPeptic UlcerRisk FactorsPeptic Ulcer HemorrhageTreatment OutcomePlatelet Function TestsDrug InteractionsSodium SalicylateChemopreventionDrug HypersensitivityColorectal NeoplasmsApoptosisAsthma, Aspirin-InducedBlood PlateletsDrug Administration ScheduleAnalgesicsTime FactorsHT29 CellsTablets, Enteric-CoatedArthritisProspective StudiesSafety-Based Drug WithdrawalsAnticoagulantsAnti-Ulcer AgentsAdministration, OralColonic NeoplasmsRandomized Controlled Trials as TopicFibrinolytic AgentsWarfarinAdenomatous Polyposis ColiDrug SynergismProton Pump InhibitorsHemorrhageLipoxinsCell Line, TumorAdenomaCardiovascular DiseasesPainProstaglandin AntagonistsPowder DiffractionAnti-Inflammatory AgentsArthritis, RheumatoidNipplesRisk AssessmentEpoprostenolCase-Control StudiesBleeding TimeLipoxygenase InhibitorsKetorolacMisoprostolThrombosisPlacebosPlatelet ActivationCohort StudiesMyocardial InfarctionThromboxanesFollow-Up StudiesPain Measurement6-Ketoprostaglandin F1 alphaAntineoplastic Agents